Furthermore, Yamamoto et al. reported that serum ALT, AST and ferritin levels were significantly decreased by restricting dietary fat and iron for 6 months in patients with NAFLD (Yamamoto et al., 2007). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.